Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

Shares of Hikma Pharmaceuticals PLC HIK slipped 2.64% to £17.72 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index UKX falling 0.07% ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

FMI’s latest analysis underscores a remarkable surge in demand for pharmaceutical products within the Kingdom, with market value expected to exceed USD 10,113.1 million by 2024. This impressive growth ...

Dividend amount and dividend per share are quoted in the currency of the stock selected. Please note that past performance is not a reliable indicator of future returns. Important Information Please ...

Ionis Pharmaceuticals (IONS) announced the pivotal Phase 3 study design following successful alignment with the U.S. FDA on ION582, an investigational medicine for the treatment of people living ...

The last decade has seen a swell of biotech startups using AI to design proteins. These are seven companies to watch.

Tamara de Lempicka’s first major U.S. survey invokes her as a trailblazing techno-feminist who borrowed freely from art history. But it also buries her erratic second act. By Walker Mimms ...